The China National biological products corporation Lrb Rrb, the largest bio Tech company in China, plans to spend 314 million yuan Lrb 61.84 million us dollars Rrb developing vaccines against severe acute respiratory syndrome Lrb Sars Rrb.
Chinese bio Tech company works on Sars vaccines.